RyCarma Therapeutics, Inc. Unveils New Leadership and Introduces New Program in Heart Failure
Position
Chief Strategy Officer
Company
RyCarma Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
RyCarma Therapeutics, Inc., formerly known as ARMGO Pharma, announced its new leadership team and company name change, introducing a new program in heart failure focused on developing its lead candidate ARM210. The new leadership team members have a track record of success in leading biotech companies and guiding novel biological discoveries through drug development.
Quick answer
RyCarma Therapeutics, Inc. Unveils New Leadership and Introduces New Program in Heart Failure (January 7, 2025). RyCarma Therapeutics is based in Boston, Massachusetts, United States.
- What did RyCarma Therapeutics announce on January 7, 2025?
- RyCarma Therapeutics, Inc., formerly known as ARMGO Pharma, announced its new leadership team and company name change, introducing a new program in heart failure focused on developing its lead candidate ARM210. The new leadership team members have a track record of success in leading biotech companies and guiding novel biological discoveries through drug development.
- What does RyCarma Therapeutics do?
- RyCarma is a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases.
- Where is RyCarma Therapeutics based?
- RyCarma Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Tarsier Pharma (January 7, 2025), City Therapeutics (January 7, 2025), Alltrna (January 6, 2025) and Amylyx Pharmaceuticals (January 6, 2025) also announced leadership changes within 45 days of RyCarma Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
- City Therapeutics Appoints Andrew Orth as Chief Executive Officer (January 7, 2025)
- Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer (CMO) (January 6, 2025)
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
- Aicuris Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer (January 8, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
Who to call at RyCarma Therapeutics, and when
A new leader at RyCarma Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day RyCarma Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RyCarma Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RyCarma Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RyCarma Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
RyCarma Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.